Lanzamiento Enero 2027

Estudio2012Solo mecanismos

Phenolic secoiridoids in extra virgin olive oil impede fibrogenic and oncogenic epithelial-to-mesenchymal transition: extra virgin olive oil as a source of novel antiaging phytochemicals

Vazquez-Martin A, Fernández-Arroyo S, Cufí S, Oliveras-Ferraros C, Lozano-Sánchez J, Vellón L, Micol V, Joven J, Segura-Carretero A, Menendez JA

Rejuvenation research · 32 citas

Etiquetas de revisión

Solo mecanismos

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Estudio in vitro o de mecanismos (clasificado por nuestro filtro de IA)
Estudiado en
Células o muestras de laboratorio
Resultado principal
Solo mecanismos

Quién lo pagó

Financiación
Financiación independiente
Gobierno
Ministerio de Ciencia e Innovación
Gobierno
Instituto de Salud Carlos III
Subvenciones
Instituto de Salud Carlos III (RD06-0020-0028); Instituto de Salud Carlos III (CD08/00283); Instituto de Salud Carlos III (CP05-00090); Instituto de Salud Carlos III (PI06-0778)

Según 2 financiadores declarados.

Publicación

Publicado
2012-01-09 · Rejuvenation Res · vol. 15 · número 1 · págs. 3–21
Editorial
Mary Ann Liebert, Inc.
Citado
41 citas · más que el 85% de estudios similares · 2.0× el promedio de su campo
Referencias
121 trabajos
Acceso
Acceso abierto (copia en repositorio)
Áreas de investigación
Edible Oils Quality and Analysis · Phytochemicals and Antioxidant Activities · Potato Plant Research
Palabras clave
Olive oil, Epithelial–mesenchymal transition, Chemistry, Mesenchymal stem cell, Food science, Transition (genetics), Cell biology, Biology, Biochemistry, Gene
MeSH
cell line, cell line, tumor, animals, dogs, humans, neoplasm metastasis, fibrosis, iridoids, phenols, phenol, plant oils, anticarcinogenic agents, microscopy, fluorescence, chromatography, high pressure liquid, diet, aging, mass spectrometry, epithelial-mesenchymal transition, real-time polymerase chain reaction, olive oil

10 autores

  • Alejandro Vázquez‐Martín🇪🇸Institut Català d'Ornitologia; Catalan Institute for Water Research; Institut Català d'Oncologia; Institut d'Investigació Biomèdica de Girona
  • Salvador Fernández‐Arroyo🇪🇸Universidad de Granada
  • Sílvia Cufí🇪🇸Institut Català d'Ornitologia; Catalan Institute for Water Research; Institut Català d'Oncologia; Institut d'Investigació Biomèdica de Girona
  • Cristina Oliveras‐Ferraros🇪🇸Institut Català d'Ornitologia; Catalan Institute for Water Research; Institut Català d'Oncologia; Institut d'Investigació Biomèdica de Girona
  • Jesús Lozano‐Sánchez🇪🇸Universidad de Granada
  • Luciano Vellón
  • Vicente Micol🇪🇸Universitat de Miguel Hernández d'Elx
  • Jorge Joven🇪🇸Institut de Recerca Biomèdica Catalunya Sud; Hospital Universitari Sant Joan de Reus; Universitat Rovira i Virgili
  • Antonio Segura‐Carretero🇪🇸 · autor de correspondenciaUniversidad de Granada
  • Javier A. Menéndez🇪🇸 · autor de correspondenciaInstitut Català d'Ornitologia; Catalan Institute for Water Research; Institut Català d'Oncologia; Institut d'Investigació Biomèdica de Girona

Resumen

El texto original del estudio, en el idioma en que se publicó.

The epithelial-to-mesenchymal transition (EMT) genetic program is a molecular convergence point in the life-threatening progression of organ fibrosis and cancer toward organ failure and metastasis, respectively. Here, we employed the EMT process as a functional screen for testing crude natural extracts for accelerated drug development in fibrosis and cancer. Because extra virgin olive oil (EVOO) (i.e., the juice derived from the first cold pressing of the olives without any further refining process) naturally contains high levels of phenolic compounds associated with the health benefits derived from consuming an EVOO-rich Mediterranean diet, we have tested the ability of an EVOO-derived crude phenolic extract to regulate fibrogenic and oncogenic EMT in vitro. High-performance liquid chromatography (HPLC) coupled to time-of-flight (TOF) mass spectrometry assays revealed that the EVOO phenolic extract was mainly composed (∼70%) of two members of the secoiridoid family of complex polyphenols, namely oleuropein aglycone-the bitter principle of olives-and its derivative decarboxymethyl oleuropein aglycone. EVOO secoiridoids efficiently prevented loss of proteins associated with polarized epithelial phenotype (i.e., E-cadherin) as well as de novo synthesis of proteins associated with mesenchymal migratory morphology of transitioning cells (i.e., vimentin). The ability of EVOO to impede transforming growth factor-β (TGF-β)-induced disintegration of E-cadherin-mediated cell-cell contacts apparently occurred as a consequence of the ability of EVOO phenolics to prevent the upregulation of SMAD4-a critical mediator of TGF-β signaling-and of the SMAD transcriptional cofactor SNAIL2 (Slug)-a well-recognized epithelial repressor. Indeed, EVOO phenolics efficiently prevented crucial TGF-β-induced EMT transcriptional events, including upregulation of SNAI2, TCF4, VIM (Vimentin), FN (fibronectin), and SERPINE1 genes. While awaiting a better mechanistic understanding of how EVOO phenolics molecularly shut down the EMT differentiation process, it seems reasonable to suggest that nontoxic Oleaceae secoiridoids certainly merit to be considered for aging studies and, perhaps, for ulterior design of more pharmacologically active second-generation anti-EMT molecules.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.